Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
163.05 EUR | -1.45% | +2.64% | +1.84% |
Dec. 11 | Wolters Kluwer Launches New Teammate+ Capabilities to Enhance Internal Audit Efficiency and Data Quality | CI |
Dec. 10 | Wolters Kluwer N.V. - Special Call |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.91 | 7.26 | 7.72 | 8.65 | 8.92 | |||||
Return on Total Capital | 11.06 | 11.66 | 12.48 | 13.97 | 14.52 | |||||
Return On Equity % | 28.87 | 32.28 | 32.33 | 43.45 | 49.62 | |||||
Return on Common Equity | 28.87 | 32.28 | 32.33 | 43.45 | 49.62 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 69.97 | 70.48 | 71.2 | 71.06 | 71.78 | |||||
SG&A Margin | 49.22 | 48.82 | 48.71 | 47.53 | 48.01 | |||||
EBITDA Margin % | 28.32 | 29.26 | 29.83 | 30.15 | 30.44 | |||||
EBITA Margin % | 27.78 | 28.7 | 29.3 | 29.67 | 30.03 | |||||
EBIT Margin % | 20.75 | 21.66 | 22.49 | 23.53 | 23.76 | |||||
Income From Continuing Operations Margin % | 14.51 | 15.66 | 15.26 | 18.83 | 18.03 | |||||
Net Income Margin % | 14.51 | 15.66 | 15.26 | 18.83 | 18.03 | |||||
Net Avail. For Common Margin % | 14.51 | 15.66 | 15.26 | 18.83 | 18.03 | |||||
Normalized Net Income Margin | 12.22 | 12.99 | 13.05 | 14.06 | 14.56 | |||||
Levered Free Cash Flow Margin | 16.47 | 18.35 | 19.11 | 20.81 | 17.51 | |||||
Unlevered Free Cash Flow Margin | 17.44 | 19.42 | 19.99 | 21.64 | 18.51 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.53 | 0.54 | 0.55 | 0.59 | 0.6 | |||||
Fixed Assets Turnover | 12.2 | 10.97 | 12.25 | 14.78 | 16.38 | |||||
Receivables Turnover (Average Receivables) | 3.91 | 3.97 | 4.25 | 4.57 | 4.49 | |||||
Inventory Turnover (Average Inventory) | 19.24 | 19.28 | 20.66 | 21.92 | 19.34 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.65 | 0.69 | 0.9 | 0.77 | 0.73 | |||||
Quick Ratio | 0.57 | 0.6 | 0.73 | 0.69 | 0.66 | |||||
Operating Cash Flow to Current Liabilities | 0.29 | 0.38 | 0.42 | 0.41 | 0.41 | |||||
Days Sales Outstanding (Average Receivables) | 93.35 | 92.28 | 85.8 | 79.89 | 81.31 | |||||
Days Outstanding Inventory (Average Inventory) | 18.97 | 18.99 | 17.67 | 16.65 | 18.88 | |||||
Average Days Payable Outstanding | 47.63 | 40.82 | 34.08 | 30.95 | 36.01 | |||||
Cash Conversion Cycle (Average Days) | 64.69 | 70.45 | 69.39 | 65.59 | 64.17 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 130.92 | 148.87 | 129.58 | 156.58 | 214.35 | |||||
Total Debt / Total Capital | 56.7 | 59.82 | 56.44 | 61.03 | 68.19 | |||||
LT Debt/Equity | 88.7 | 123.43 | 126.23 | 122.51 | 176.44 | |||||
Long-Term Debt / Total Capital | 38.41 | 49.6 | 54.98 | 47.75 | 56.13 | |||||
Total Liabilities / Total Assets | 72.88 | 75.1 | 73.23 | 75.71 | 80.77 | |||||
EBIT / Interest Expense | 13.48 | 12.62 | 16.01 | 17.82 | 14.91 | |||||
EBITDA / Interest Expense | 19.41 | 17.97 | 22.3 | 23.82 | 19.85 | |||||
(EBITDA - Capex) / Interest Expense | 16.23 | 17.66 | 18.72 | 19.72 | 16.21 | |||||
Total Debt / EBITDA | 2.26 | 2.19 | 2.1 | 2.11 | 2.12 | |||||
Net Debt / EBITDA | 1.61 | 1.68 | 1.43 | 1.32 | 1.48 | |||||
Total Debt / (EBITDA - Capex) | 2.7 | 2.23 | 2.5 | 2.55 | 2.6 | |||||
Net Debt / (EBITDA - Capex) | 1.92 | 1.71 | 1.7 | 1.6 | 1.81 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 8.29 | -0.2 | 3.65 | 14.29 | 2.4 | |||||
Gross Profit, 1 Yr. Growth % | 8.95 | 0.53 | 4.72 | 14.07 | 3.43 | |||||
EBITDA, 1 Yr. Growth % | 8.56 | 3.14 | 7.15 | 15.53 | 3.41 | |||||